123 related articles for article (PubMed ID: 27746118)
41. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
Zeng X; Morgenstern R; Nyström AM
Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
[TBL] [Abstract][Full Text] [Related]
42. Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins.
Işeri OD; Kars MD; Arpaci F; Gündüz U
Cancer Chemother Pharmacol; 2010 Feb; 65(3):447-55. PubMed ID: 19543729
[TBL] [Abstract][Full Text] [Related]
43. P-glycoprotein expression and chemosensitivity in highly purified fresh human gastrointestinal cancer cells.
Hotta T; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Noguchi K; Mizobata S; Arii K; Terasawa H; Nakamori M; Yamaue H
Hepatogastroenterology; 1999; 46(25):316-21. PubMed ID: 10228815
[TBL] [Abstract][Full Text] [Related]
44. Drug resistant breast cancer cells overexpress ETS1 gene.
Kars MD; Işeri OD; Gündüz U
Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592
[TBL] [Abstract][Full Text] [Related]
45. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.
Foley JM; Scholten DJ; Monks NR; Cherba D; Monsma DJ; Davidson P; Dylewski D; Dykema K; Winn ME; Steensma MR
J Transl Med; 2015 Apr; 13():110. PubMed ID: 25889105
[TBL] [Abstract][Full Text] [Related]
46. Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin.
Ravizza R; Gariboldi MB; Passarelli L; Monti E
BMC Cancer; 2004 Dec; 4():92. PubMed ID: 15601469
[TBL] [Abstract][Full Text] [Related]
47. Genome-wide profiles of methylation, microRNAs, and gene expression in chemoresistant breast cancer.
He DX; Gu F; Gao F; Hao JJ; Gong D; Gu XT; Mao AQ; Jin J; Fu L; Ma X
Sci Rep; 2016 Apr; 6():24706. PubMed ID: 27094684
[TBL] [Abstract][Full Text] [Related]
48. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
49. Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line.
AbuHammad S; Zihlif M
Genomics; 2013 Apr; 101(4):213-20. PubMed ID: 23201559
[TBL] [Abstract][Full Text] [Related]
50. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.
Amornsupak K; Insawang T; Thuwajit P; O-Charoenrat P; Eccles SA; Thuwajit C
BMC Cancer; 2014 Dec; 14():955. PubMed ID: 25512109
[TBL] [Abstract][Full Text] [Related]
51. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
Pistore C; Giannoni E; Colangelo T; Rizzo F; Magnani E; Muccillo L; Giurato G; Mancini M; Rizzo S; Riccardi M; Sahnane N; Del Vescovo V; Kishore K; Mandruzzato M; Macchi F; Pelizzola M; Denti MA; Furlan D; Weisz A; Colantuoni V; Chiarugi P; Bonapace IM
Oncogene; 2017 Oct; 36(40):5551-5566. PubMed ID: 28581528
[TBL] [Abstract][Full Text] [Related]
52. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
[TBL] [Abstract][Full Text] [Related]
53. Differential expression of multidrug resistance‑related proteins in adriamycin‑resistant (pumc‑91/ADM) and parental (pumc‑91) human bladder cancer cell lines.
Zhao M; Yu S; Zhang M
Mol Med Rep; 2016 Nov; 14(5):4741-4746. PubMed ID: 27748815
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
Tormo E; Pineda B; Serna E; Guijarro A; Ribas G; Fores J; Chirivella E; Climent J; Lluch A; Eroles P
J Cell Biochem; 2015 Sep; 116(9):2061-73. PubMed ID: 25802200
[TBL] [Abstract][Full Text] [Related]
55. Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10.
Morikawa Y; Kezuka C; Endo S; Ikari A; Soda M; Yamamura K; Toyooka N; El-Kabbani O; Hara A; Matsunaga T
Chem Biol Interact; 2015 Mar; 230():30-9. PubMed ID: 25686905
[TBL] [Abstract][Full Text] [Related]
56. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
[TBL] [Abstract][Full Text] [Related]
57. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
58. Autophagy and doxorubicin resistance in cancer.
Chen C; Lu L; Yan S; Yi H; Yao H; Wu D; He G; Tao X; Deng X
Anticancer Drugs; 2018 Jan; 29(1):1-9. PubMed ID: 29099416
[TBL] [Abstract][Full Text] [Related]
59. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.
Xu P; Wang L; Huang L; Li W; Lv S; Lv M; Ma J; Zhou Q; Wu X; Fu Z; Lu C; Yin H
Biomed Pharmacother; 2015 Oct; 75():173-8. PubMed ID: 26293775
[TBL] [Abstract][Full Text] [Related]
60. Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells.
Mamidipudi V; Shi T; Brady H; Surapaneni S; Chopra R; Aukerman SL; Heise C; Sung V
Cancer Chemother Pharmacol; 2012 Apr; 69(4):965-76. PubMed ID: 22120960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]